Corden Pharma
Corden Pharma, headquartered in Luxembourg (LU), is a leading contract development and manufacturing organisation (CDMO) specialising in the pharmaceutical and biotechnology sectors. Founded in 2006, the company has established a strong presence across Europe and North America, providing comprehensive services that encompass drug development, active pharmaceutical ingredient (API) production, and finished dosage forms. Corden Pharma is renowned for its expertise in complex formulations and high-potency compounds, setting it apart in a competitive market. With a commitment to quality and innovation, the company has achieved significant milestones, including the expansion of its manufacturing capabilities and the successful launch of numerous client products. Corden Pharma's dedication to excellence has solidified its position as a trusted partner for pharmaceutical companies seeking reliable and efficient solutions.
DitchCarbon Score
How does Corden Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Corden Pharma's score of 31 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Corden Pharma's reported carbon emissions
Corden Pharma, headquartered in Luxembourg, has committed to achieving net-zero carbon emissions across all scopes by 2050. Although specific emissions data for the most recent year is not available, the company has established a long-term commitment to reduce its carbon footprint, starting from 2023. This initiative aligns with industry standards and reflects a proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. Corden Pharma's commitment to net-zero emissions demonstrates its dedication to sustainability and responsible environmental stewardship. The company is actively engaged in setting science-based targets, ensuring that its climate strategies are grounded in rigorous scientific principles. As part of its commitment, Corden Pharma has been recognised for its alignment with the Science Based Targets initiative (SBTi), which underscores its accountability in addressing climate change. While specific reduction targets and achievements have not been disclosed, Corden Pharma's pledge to net-zero emissions signifies a significant step towards mitigating its environmental impact and contributing to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Corden Pharma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
